Newmed Energy-limited Partnership, IL0004750209

NewMed Energy terminates USD 6.70 billion deal: what it means for NewMed Energy stock

Published on 10/12/2026 at 09:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The gas contract covers USD 6.70 billion over 20 years. For NewMed Energy stock this means a 45.34 percent Leviathan interest.

Key points in brief

NewMed Energy terminated a USD 6.70 billion, 20-year gas agreement on October 7, 2026.
The deal remains disputed because Dalia Energy says the contract is in force.
NewMed Energy holds a 45.34 percent interest in Leviathan and 30.00 percent in Aphrodite.
The TASE price stood at ILA 1,574.00 on October 12, 2026, while market capitalization was ILA 18.5 billion.

Newmed Energy-limited Partnership, IL0004750209, Illustration mit AI erstellt.

NewMed Energy (IL0004750209) terminated a USD 6.70 billion gas agreement on October 7, 2026, reviving a dispute over a 20-year supply contract. NewMed Energy listed the termination notice in its immediate reports, while Globes reported that Dalia Energy insists the agreement remains in force.

Three events changed the picture

On September 23, 2026, NewMed announced a GeoIntelX collaboration covering exploration data for two flagship projects. The partnership described NewMed's portfolio as including a 45.34 percent Leviathan interest and a 30.00 percent Aphrodite interest, according to PR Newswire.

On October 6, 2026, the Competition Authority approved the USD 6.70 billion Leviathan gas deal in full, according to Globes. One day later, NewMed maintained that contractual preconditions had not been fulfilled, leaving the 20-year agreement at the center of the stock story.

What does the dispute mean for gas sales?

The dispute puts the value and timing of the USD 6.70 billion contract ahead of the partnership's broader production profile. Dalia Energy's position creates a direct counterpoint to NewMed's termination notice, so the commercial outcome depends on how the contract's conditions are interpreted and enforced.

The underlying asset base remains concentrated. NewMed's 45.34 percent Leviathan interest is larger than its 30.00 percent Aphrodite interest, giving Leviathan the greater numerical weight in the portfolio description. That comparison matters because the disputed contract is tied to Leviathan gas supply.

TASE price remains the market reference

NewMed Energy was trading at ILA 1,574.00 on the Tel Aviv Stock Exchange on October 12, 2026 at 10:23 a.m. IDT. The company describes itself as an Israel-focused offshore gas partnership with production, development and exploration assets in the Mediterranean region.